Related Experiment Videos
Effects of converting enzyme inhibitor on hepatic blood flow in man
Insights
The angiotensin converting enzyme inhibitor captopril significantly reduced mean arterial pressure in patients with essential hypertension. However, it also led to a substantial decrease in hepatic blood flow.
Area of Science:
- Cardiology
- Pharmacology
- Hepatology
Background:
- Essential hypertension is a common cardiovascular condition.
- Angiotensin converting enzyme (ACE) inhibitors are widely used to manage hypertension.
- The impact of ACE inhibitors on hepatic blood flow requires further investigation.
Purpose of the Study:
- To investigate the acute effects of captopril on hepatic blood flow.
- To assess the systemic hemodynamic changes induced by captopril in hypertensive patients.
Main Methods:
- A study involving six patients diagnosed with essential hypertension.
- Administration of the oral ACE inhibitor, captopril.
- Measurement of systemic hemodynamic parameters and hepatic blood flow before and after captopril administration.
Main Results:
- Mean arterial pressure decreased significantly (p < 0.05) one hour post-captopril.
- Hepatic blood flow showed a significant uniform decrease (p < 0.001) from 1,127 to 841 ml/min.
- No significant changes were observed in other measured hemodynamic values.
Conclusions:
- Captopril effectively lowers blood pressure in essential hypertension.
- The acute administration of captopril results in a significant reduction in hepatic blood flow.
- Further research is needed to understand the clinical implications of reduced hepatic blood flow during ACE inhibitor therapy.
Abstract:
The acute effects of the oral angiotension converting enzyme inhibitor captopril on hepatic blood flow and systemic hemodynamics were studied in six patients with essential hypertension. Mean arterial pressure decreased from 141.9 +/- 6.9 mm Hg to 130.2 +/- 6.7 mm Hg (p less than 0.05) one hour after the administration of captopril. There was no significant change in other hemodynamic values, but hepatic blood flow decreased uniformly from 1,127 +/- 115 ml per minute to 841 +/- 93 ml per minute (p less than 0.001).